Company / Shares Outstanding
Corbus Pharmaceuticals Holdings, Inc. Shares Outstanding History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
4.2M
FY2022
5-year range
4.2M / 98.9M
FY2018-FY2022
Trend
-95.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 64672893.00 to 4169631.00 over the past 2 years.
Based on SEC 10-K filings.
4169631.00 in FY2022 with a 5-year CAGR of -35.6%.
Improved from 64672893.00 to 4169631.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -58.2%
- 5-Year CAGR
- -35.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, shares outstanding decreased 95.8% year-over-year.
- Peak shares outstanding was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | 4.2M | -95.8% |
| FY2021 | 98.9M | +52.9% |
| FY2020 | 64.7M | +13.0% |
| FY2019 | 57.2M | +3.0% |
| FY2018 | 55.6M | +47.9% |
| FY2017 | 37.6M | +0.0% |
| FY2016 | 37.6M | +45.0% |
| FY2015 | 25.9M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026